Swiss CDMO Siegfried has signed a binding agreement with compatriot Novartis to acquire two pharmaceutical manufacturing sites in Spain. The Zofingen-based group said...
German biotech BioNTech has signed a share purchase agreement with Novartis to acquire the Swiss drugmaker’s GMP-certified manufacturing facility in Marburg, Germany. The...
Pharmaceuticals heavyweight Novartis is changing the name of its previously indirect subsidiary AveXis to Novartis Gene Therapies. The Swiss drugmaker said the change...
The Austrian government is sharing a third of the cost of a €150 million upgrade Novartis' generics unit Sandoz is stemming at its Kundl, Austria, facility. The Swiss...
Novartis has finally wrapped up a suite of bribery-related lawsuits in the US, paying well over $1 billion to settle two long running multifaceted cases within a week.
03.06.2020
- Novartis's gene therapy unit AveXis has signed an agreement to produce a novel genetic COVID-19 vaccine being developed by the US-based Mass General Brigham health care system...
15.04.2020
- The pharmaceutical industry has been slowly, but surely, embracing continuous manufacturing (CM) over the past decade. In fact, most large pharma companies have invested in...
14.04.2020
- Through a combination of equity and debt, private equity giant Blackstone will invest up to $2 billion in Cambridge, Massachusetts-based US biotech Alnylam Pharmaceuticals. The...
